|
advertisement
|
|
TOP STORIES
Updates on COVID-19 vaccine candidates, FDA policies, company partnerships, and more.
/ read more /
|
| |
|
Funding from the US government could lead to 300 million coronavirus vaccine doses by October 2020.
/ read more /
|
|
| |
ADVERTISEMENT
Featured Resources from BioPharm International
View our online resource center, sponsored by GE Healthcare, to explore a case study and articles on gaining and retaining skilled labor, modular bioprocessing, the good and bad of biosilimiars, and more.
Learn More »  |
| |
|
SubscribeSubscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.
subscription offers
|
|
|
Industry News
This latest round of funding adds 14 new technology projects, workforce development, and Global Health Fund projects to NIIMBL's portfolio.
/ read more /
The International Coalition of Medicines Regulatory Authorities held a virtual meeting of regulators from around the world to discuss policy issues and regulatory requirements to respond to the ongoing COVID-19 pandemic.
/ read more /
MORE INDUSTRY NEWS
|
| |
|
|
ADVERTISEMENT
KNAUER supports SARS-CoV-2 research
Liquid chromatography is a central tool in research revolving around vaccine and therapeutic development for SARS-CoV-2. Chromatography is not only limited to one aspect of research. It can be used in multiple ways ranging from analytical tasks to preparative purification and protein purification. With more than 55 years’ experience in research, KNAUER is a committed partner to help advance SARS-CoV-2 research.
Learn More » |
| |
Biopharma News
Participants in two dosing cohorts in Moderna’s mRNA-1273 study reached or exceeded neutralizing antibody titers generally seen in convalescent sera.
/ read more /
CanSinoBIO will license-in Precision NanoSystems' proprietary RNA vaccine platform technology while the latter leads the development of the RNA vaccine formulation.
/ read more /
More Biopharma News
|
| |
|
Supplier News
Vibalogics is contracted to manufacture Janssen's COVID-19 candidate vaccine at its GMP-accredited facility in Cuxhaven, Germany.
/ read more /
|
|
Ori Biotech is partnering with manufacturers and materials suppliers to develop an automated system for cell and gene therapy manufacturing.
/ read more /
More Supplier News
|
|
Regulatory News
The European Medicines Agency is emphasizing the need for the research community to pool resources to determine which COVID-19 treatments and preventions are safe and effective.
/ read more /
|
The EU Executive Steering Group on Shortages of Medicines Caused by Major Events met on May 13, 2020 to discuss measures the European Union is taking to ensure the availability of medicines during the COVID-19 pandemic.
/ read more /
More Regulatory News
|
|
|
|
|
|
PEER-REVIEW RESEARCH
In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.
/ read more /
|
|
|
|
|
ANALYTICS
Next-generation therapeutics and regulatory requirements create demand for complex, fit-for-purpose tests
/ read more /
|
|
|
|
MANUFACTURING
Viral vectors show promise as a delivery mechanism for gene therapy, but which virus types are commercially viable?
/ read more /
|
|
|
eBook
|
The Pharmacopoeia Compliance Series features a description of ways biopharma companies can participate in monograph development, a case study of a practical approach to pharmacopoeial compliance, and a summary of this 12-part series.
|
|
|
|
| |
